" /> t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen - CISMeF





Preferred Label : t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen;

LOINC status : ACTIVE;

LOINC display name : t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript Molgen (BM) [# ratio];

LOINC long common name : t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method;

LOINC short name : t(8;21)(RUNX1T1,RUNX1)/control Mar;

LOINC description : Translocations between chromosomes 8 and 21, resulting in a fused transcript between RUNXT1 (8q22) and RUNX1 (21q22.3), can be detected with real-time PCR. An endogenous control gene transcript (e.g. ABL1, GUS or BCR) is amplified along with the fusion transcript of interest. Standard curves of known amounts of both the control and fusion transcript are used to calculate the ratio of the fusion transcript signal to the control gene signal.;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.